Scabies Management

First-Line Treatment Options

• The American Academy of Dermatology recommends permethrin 5% cream as the first-line treatment for scabies, applied to all areas of the body from the neck down and washed off after 8-14 hours 1, 2
• Oral ivermectin is recommended as a first-line treatment option, with a dosage of 200 μg/kg body weight, taken with food to increase bioavailability, and a second dose after 2 weeks 1, 3

Alternative Treatment Options

• The Centers for Disease Control and Prevention recommends lindane (1%) as an alternative treatment option, applied thinly to all areas from neck down and washed off after 8 hours 2
• Sulfur (6%) ointment is recommended as an alternative treatment option, applied thinly to affected areas nightly for 3 nights, washing off previous applications before reapplying 2

Special Populations

• The American College of Obstetricians and Gynecologists recommends permethrin 5% cream as the preferred treatment option for pregnant or lactating women 4, 1
• Children under 10 years should avoid lindane due to risk of neurotoxicity, and use permethrin instead 3, 4
• Persons with extensive dermatitis should avoid lindane due to increased absorption and risk of seizures 2, 3
• Immunocompromised patients are at higher risk for crusted (Norwegian) scabies, requiring more aggressive treatment 2

Crusted (Norwegian) Scabies Management

• Combination therapy is recommended for crusted (Norwegian) scabies, including 5% permethrin cream applied daily for 7 days, then twice weekly until cure, plus oral ivermectin 200 μg/kg on days 1, 2, 8, 9, and 15 1, 2

Environmental Management

• Decontaminate bedding and clothing by machine washing and drying using hot cycle, dry cleaning, or removing from body contact for at least 72 hours 1, 2, 4
• Fumigation of living areas is unnecessary 2
• Keep fingernails closely trimmed to reduce injury from scratching 3

Contact Management

• Examine and treat all persons who have had sexual, close personal, or household contact with the patient within the preceding month 2, 1
• For institutional outbreaks, treat the entire population at risk and consult with an expert 2

Follow-Up and Treatment Failure

• Pruritus may persist for up to 2 weeks after successful treatment 2, 1
• Consider retreatment if symptoms persist beyond 2 weeks, live mites are observed, or other signs of treatment failure are present 2, 1
• Reasons for treatment failure include resistance to medication, faulty application of topical treatments, reinfection from untreated contacts or fomites, and cross-reactivity with other household mites 1, 3

Treatment Pitfalls to Avoid

• Failure to treat all close contacts simultaneously 1
• Inadequate application of topical treatments 1
• Using lindane after bathing or in contraindicated populations 1, 3
• Not repeating ivermectin dose after 2 weeks 1
• Expecting immediate resolution of symptoms (may take up to 2 weeks) 2, 1

Scabies Treatment Guidelines

Introduction to Scabies Treatment

• The Centers for Disease Control and Prevention recommends lindane 1% as a treatment option, but it is contraindicated in children <10 years, pregnant/lactating women, and persons with extensive dermatitis 5
• Crotamiton 10% can be applied nightly for 2 consecutive nights, washed off 24 hours after second application, as an alternative treatment for scabies 5

Alternative Treatment Options

• Benzyl benzoate 25% has shown an 87% cure rate, but may cause a burning sensation in 43% of patients, and can be considered when permethrin fails or is unavailable 5
• Lindane 1% should not be used after bathing, as it increases absorption and seizure risk, according to the MMWR Recommendations and Reports 5

Scabies Treatment Guidelines

First-Line Treatment

• The Centers for Disease Control and Prevention recommends permethrin 5% cream as the preferred first-line treatment for scabies in otherwise healthy individuals, applied from the neck down and washed off after 8-14 hours 6
• Permethrin 5% cream is more effective, safer, and less expensive than ivermectin for standard scabies 6
• Infants, elderly, and immunocompromised patients require scalp-to-toes application of permethrin 5% cream, including hairline, neck, temple, and forehead 6

Alternative Treatment Options

• The Centers for Disease Control and Prevention recommends oral ivermectin as an alternative first-line treatment, with a dosage of 200 μg/kg body weight, repeated in 2 weeks 6
• Ivermectin must be taken with food to increase bioavailability and epidermal penetration 6
• The second dose of ivermectin is essential because it has limited ovicidal activity and does not kill eggs present at initial treatment 6

Special Populations

• The Centers for Disease Control and Prevention recommends permethrin 5% cream as the preferred treatment for pregnant and lactating women 6
• Ivermectin is classified as "human data suggest low risk" in pregnancy and probably compatible with breastfeeding 6
• Permethrin is recommended for infants and young children, and must include scalp, temple, and forehead in application 6

Environmental and Contact Management

• The Centers for Disease Control and Prevention recommends machine washing and drying bedding and clothing using hot cycle, dry cleaning, or removing from body contact for at least 72 hours to prevent reinfection 6
• Fumigation of living areas is unnecessary 6
• All persons with sexual, close personal, or household contact within the preceding month must be treated simultaneously to prevent reinfection 6

Follow-Up and Retreatment

• The Centers for Disease Control and Prevention recommends evaluating patients after 1 week if symptoms persist, and considering retreatment after 2 weeks if symptoms persist or live mites are observed 6
• Persistent pruritus alone is not an indication for retreatment, as it may represent a sensitization reaction rather than active infestation 6

CDC Recommendations for Scabies Treatment

First‑Line Therapy for Classic Scabies

• Permethrin 5 % cream applied to the entire body from the neck down (or scalp‑to‑toes in infants, young children, elderly, and immunocompromised patients) and washed off after 8–14 h is the preferred first‑line treatment and is generally curative with a single application. 7
• Oral ivermectin given at a weight‑based dose (≈200 µg/kg) with a second identical dose 2 weeks later provides efficacy comparable to permethrin; the medication should be taken with food to improve absorption. 7
• The second ivermectin dose is essential because the drug has limited activity against mite eggs present at the initial treatment. 7
• Ivermectin is contraindicated in children weighing less than about 15 kg or younger than 10 years because of potential neurotoxicity. 7
• No dose adjustment of ivermectin is required for renal impairment; safety of multiple doses in severe liver disease remains uncertain. 7

Age‑Specific Application Guidance

• Adults and children ≥10 years: apply permethrin from the neck down only; avoid the scalp unless the patient is immunocompromised.** 7
• Infants, young children (<2 years), elderly, and immunocompromised patients: apply permethrin to the entire body, including scalp, hairline, neck, temples, and forehead.** 7

Treatment in Special Populations

Pregnant and Lactating Women

• Permethrin 5 % cream remains the preferred therapy for pregnant or lactating individuals. 7
• Lindane is absolutely contraindicated because of its association with neural‑tube defects and accumulation in placenta and breast milk. 7

Infants and Young Children

• Permethrin is recommended even for infants younger than 2 months. 7
• Lindane must never be used in children younger than 10 years due to a high risk of seizures and neurotoxicity. 7

Immunocompromised Patients

• These patients are at higher risk for crusted scabies and treatment failure and should receive scalp‑to‑toes permethrin application regardless of age. 7

Management of Crusted (Norwegian) Scabies

• Aggressive combination therapy is required: permethrin 5 % cream applied daily for 7 days, then twice weekly until cure, together with oral ivermectin (weight‑based dose) on days 1, 2, 8, 9, 15 (additional doses on days 22 and 29 for severe disease). 7
• A single application of permethrin or a single oral ivermectin dose is insufficient and will fail because of the massive mite burden. 7
• Crusted scabies occurs primarily in immunodeficient, debilitated, or malnourished persons and is markedly more contagious than typical scabies. 7
• Lindane must be avoided in this population due to the risk of neurotoxicity with extensive skin involvement. 7
• Specialist consultation is advised for the management of crusted scabies. 7

Lindane: Contraindications and Safety Concerns

• Do not use lindane in children <10 years, pregnant or lactating women, individuals with extensive dermatitis, or immediately after bathing. 7
• Seizures have been reported when lindane is applied after a bath or in patients with widespread dermatitis. 7
• Aplastic anemia and emerging resistance have also been documented with lindane use. 7

Contact and Environmental Management

• All household, sexual, or close personal contacts within the preceding month should be examined and treated simultaneously, even if asymptomatic. 7
• Bedding and clothing should be machine‑washed and dried on a hot cycle, dry‑cleaned, or isolated from body contact for at least 72 hours. 7
• Environmental fumigation is unnecessary. 7
• Trim fingernails closely to reduce skin injury from scratching. 7
• In institutional outbreaks, treat the entire at‑risk population concurrently, preferably with mass oral ivermectin for ease of administration. 7

Follow‑Up, Retreatment, and Post‑Treatment Symptoms

• Pruritus and rash may persist for up to 2 weeks after successful therapy due to allergic dermatitis, not treatment failure. 7
• Persistent itching alone does not warrant retreatment. 7
• Retreatment is indicated only after 2 weeks if live mites are observed, symptoms continue beyond 2 weeks, or new lesions appear; an alternative regimen should then be used. 7

Common Reasons for Treatment Failure

• Medication resistance or incorrect application of topical scabicides. 7
• Re‑infection from untreated contacts or fomites. 7
• Failure to treat all close contacts simultaneously. 7
• Omission of the second ivermectin dose at 2 weeks. 7
• Use of lindane after bathing or in contraindicated populations. 7

Critical Pitfalls to Avoid

• Do not apply topical corticosteroids during active scabies treatment, as they may suppress the inflammatory response and allow mite proliferation. 7
• Do not skip the second ivermectin dose at 2 weeks. 7
• Do not rely on a single permethrin application for crusted scabies; this regimen will fail. 7
• Do not expect immediate resolution of symptoms; allow up to 2 weeks for post‑treatment pruritus to subside. 7
• Do not use lindane in children <10 years, pregnant or lactating women, after bathing, or in patients with extensive dermatitis. 7

Emerging Resistance Concerns

• A 2024 double‑blind randomized controlled trial reported a cure rate of only 27 % with permethrin versus 87 % with benzyl benzoate, indicating possible reduced sensitivity of scabies mites to permethrin in some regions. 7
• Despite these findings, current CDC and FDA guidelines continue to endorse permethrin as first‑line therapy; clinicians should maintain a low threshold for switching to alternative agents when treatment fails. 7